SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy’s cancels deal with JB chemicals

27 Sep 2011 Evaluate

Dr Reddy’s Laboratories (DRL) called off a deal to acquire the prescription portfolio of JB Chemicals and Pharmaceuticals in Russia owing to differences over valuation and other operational issues. Earlier in July, Dr Reddy’s Laboratories had entered in to an agreement with the Mumbai-based pharmaceutical firm to acquire 20 key prescription brands marketed by JB Chemicals in Russia and Common Wealth of Independent States (CIS) regions. The transaction involved sale of product registrations and intellectual property rights for a consideration of $35 million. The acquisition was supposed to expand Dr Reddy’s prescription, hospital and over the-counter market portfolio.

Dr. Reddys Lab Share Price

1279.70 -13.55 (-1.05%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×